A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/SVHM/239 (ERM Project ID: 42111)
NMA SSA Reference Number: SSA/42111/MonH-2019-165327(v3)
Monash Health Ref: RES-19-0000-125X
Effective start/end date4/03/193/03/24


  • clinical trial
  • systemic lupus erythematosus (SLE)
  • treatment efficacy